» Authors » Monika Herian

Monika Herian

Explore the profile of Monika Herian including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 14
Citations 93
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Grzesiak M, Herian M, Kaminska K, Ajersch P
Adv Protein Chem Struct Biol . 2024 Jul; 142:99-130. PMID: 39059995
Vitamin D is a fat-soluble secosteroid predominantly synthesized in the skin or delivered with a diet. Nevertheless, recently it is considered more as a hormone than a vitamin due to...
2.
Wojtas A, Herian M, Mackowiak M, Solarz A, Wawrzczak-Bargiela A, Bysiek A, et al.
Neuropharmacology . 2023 Sep; 240:109713. PMID: 37689261
2-(4-Bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)etanoamine (25B-NBOMe) is a highly selective 5-HT receptor agonist, exhibiting a potent hallucinogenic activity. In the present study, we investigated the effect of a 7-day treatment with 25B-NBOMe in a...
3.
Diviccaro S, Herian M, Cioffi L, Audano M, Mitro N, Caruso D, et al.
Andrology . 2023 Aug; 12(3):674-681. PMID: 37621185
Despite its efficacy for treating androgenetic alopecia, finasteride, an inhibitor of 5α-reductase (i.e., the enzyme converting testosterone, T, into dihydrotestosterone, DHT), is associated with several side effects including sexual dysfunction...
4.
Herian M, Swit P
Crit Rev Toxicol . 2023 Apr; 53(1):15-33. PMID: 37115704
Recently, a growing number of reports have indicated a positive effect of hallucinogenic-based therapies in different neuropsychiatric disorders. However, hallucinogens belonging to the group of new psychoactive substances (NPS) may...
5.
Falvo E, Giatti S, Diviccaro S, Cioffi L, Herian M, Brivio P, et al.
Int J Mol Sci . 2023 Jan; 24(2). PMID: 36674713
Patients affected by diabetes mellitus (DM) show diabetic encephalopathy with an increased risk of cognitive deficits, dementia and Alzheimer's disease, but the mechanisms are not fully explored. In the male...
6.
Diviccaro S, Falvo E, Piazza R, Cioffi L, Herian M, Brivio P, et al.
Neuropharmacology . 2022 Dec; 226:109405. PMID: 36572179
Sex steroid hormones are not only synthesized from the gonads but also by other tissues, such as the brain (i.e., neurosteroids) and colon (i.e., gut steroids). Gut microbiota can be...
7.
Diviccaro S, Giatti S, Cioffi L, Falvo E, Herian M, Caruso D, et al.
Biomolecules . 2022 Nov; 12(11). PMID: 36358917
The treatment with finasteride (i.e., an inhibitor of 5α-reductase) may be associated with different side effects (i.e., depression, anxiety, cognitive impairment and sexual dysfunction) inducing the so-called post finasteride syndrome...
8.
Wojtas A, Bysiek A, Wawrzczak-Bargiela A, Szych Z, Majcher-Maslanka I, Herian M, et al.
Int J Mol Sci . 2022 Jun; 23(12). PMID: 35743159
Clinical studies provide evidence that ketamine and psilocybin could be used as fast-acting antidepressants, though their mechanisms and toxicity are still not fully understood. To address this issue, we have...
9.
Herian M, Wojtas A, Mackowiak M, Wawrzczak-Bargiela A, Solarz A, Bysiek A, et al.
Sci Rep . 2022 Feb; 12(1):2939. PMID: 35190675
4-Iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25I-NBOMe) is a new psychoactive substance with strong hallucinogenic properties. Our previous data reported increased release of dopamine, serotonin, and glutamate after acute injections and a tolerance development in...
10.
Herian M, Skawski M, Wojtas A, Sobocinska M, Noworyta K, Golembiowska K
Psychopharmacology (Berl) . 2021 May; 238(8):2349-2364. PMID: 34032876
Rationale: 4-Iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25I-NBOMe) is a potent serotonin 5-HT receptor agonist with hallucinogenic activity. There is no data on the 25I-NBOMe effect on brain neurotransmission and animal performance after chronic administration....